Lacerta BioCapital

Lacerta BioCapital, a member of Farmavita.Net, invests in sound, stable companies in promising Life Science segments with attractive futures (e.g., sustained positive cash flow; value increase potential of at least 20% p.a.; growth potential either organically or through acquisition; etc.). Our target companies have a sound customer base with a well balanced product portfolio. We aim to have a total investment budget of approximately €300 million (including credit capital), to be invested in around 10-15 Life Science companies.

Please contact us for introduction to Lacerta BioCapital. 

Lacerta BioCapital aims to sustain and develop our investments. Our aim is not to withdraw after a predefined period and to take account of lucrative resale opportunities only after careful due diligence. Our investment criteria are:

• Niche Life Science market segments with good profit margins
• Growing internationalisation with market growth potential
• High potential through 'buy and build'
• Dominated by small to medium-sized companies, with many 'hidden champions‘
• Opportunities for differentiation
• Exploitation of market potential
• Long-term client relationships

Lacerta BioCapital is fully committed to investing in companies solely within the Life Science industry. We do not look for startup companies as we have a focus at investments in later stages of company development. In general, we look for companies with turnover of €10-50 million, sustainable positive cash flow, stable profit situation, and opportunity for profit increase. Investment triggers would typically be management buy-outs and buy-ins, buy-and-build, succession plans, break-up of conglomerates, expansion funding, restructuring in exceptional circumstances.

Lacerta BioCapital seeks to invest in the following Life Science business segments:

• Ethical Pharmaceuticals
• Medical Devices and Equipment
• Preclinical and Clinical Contract Research Organizations (CROs)
• Contract Manufacturing Organizations (CMOs)
• Allied Life Science Services - logistics, SaaS, security, etc.

Please contact us for introduction to Lacerta BioCapital.

• The Funded (27/12/2007)
• MojKapital.com (18/07/2007)
• About us (15/12/2005)

• Looking for Strategic Investor (29/05/2009)
• Turkey - Company for Sale (19/05/2009)

---